Haoxi Health Technology Limited announced a three‑year strategic cooperation agreement with Eaglepoint AI Inc., a subsidiary of Global Mofy AI Limited, on March 3 2026. The partnership focuses on joint research and development, data sharing, and channel resource collaboration, with the goal of expanding Haoxi Health’s service portfolio beyond short‑video marketing into AI‑enabled preventive healthcare solutions.
Under the deal, Eaglepoint AI will provide technical support for model training, data security compliance, and algorithm iteration, deploying its Aquila data engine and multimodal model‑evaluation system. Haoxi Health will contribute its extensive marketing networks to drive user reach and commercial conversion for the new AI products. The first phase of the collaboration will launch the “AI Digital Health Manager” SaaS platform, targeting sub‑healthy and chronic‑disease populations and offering intelligent nutrition, chronic‑disease risk assessment, and digital therapeutics.
The agreement comes at a time when Haoxi Health’s financial performance has been uneven. FY2024 revenue rose 72% to $48.52 million, but FY2025 revenue fell 32.4% to $32.8 million, while net income improved from $1.29 million to $1.29 million, reflecting a shift in profitability dynamics. The partnership is therefore seen as a strategic move to diversify revenue streams and mitigate the company’s recent revenue decline and margin compression.
CEO Fan Zhen emphasized the complementary strengths of the two firms: “Haoxi Health has managed tens of billions of online advertising data points for healthcare clients, while Eaglepoint AI brings advanced data governance and multimodal model‑evaluation capabilities. By combining our marketing reach with Eaglepoint’s algorithmic strengths, we can deliver personalized, quantifiable health‑management solutions that meet the growing demand for preventive care.”
The collaboration is expected to strengthen Haoxi Health’s competitive position against larger digital‑marketing incumbents by adding high‑margin AI services to its portfolio. Eaglepoint’s Aquila platform, which has reportedly improved model‑iteration efficiency by 3.5×, is anticipated to accelerate product development and reduce time‑to‑market for the new SaaS offering. The partnership also positions Haoxi Health to capture a growing share of the preventive‑health market, which is projected to expand as consumers seek data‑driven wellness solutions.
The deal’s financial terms were not disclosed, but the multi‑year commitment signals confidence from both parties in the strategic fit and anticipated value creation. The partnership aligns with Haoxi Health’s broader strategy to transform from a marketing agency into a full‑stack digital‑health platform, potentially unlocking new high‑growth revenue streams and improving profitability over the long term.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.